Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	GCI Acquisition	Sexton Acquisition	Common Stock	Common Stock GCI Acquisition	Common Stock Sexton Acquisition	Additional Paid-in Capital	Additional Paid-in Capital GCI Acquisition	Additional Paid-in Capital Sexton Acquisition	Accumulated Other Comprehensive Loss	Accumulated Deficit	Series A Preferred Stock	Series A Preferred Stock Preferred Stock
Preferred stock, beginning balance (in shares) at Dec. 31, 2020													0
Beginning balance at Dec. 31, 2020	$ 204,429			$ 33			$ 302,598			$ 0	$ (98,202)		$ 0
Common stock, beginning balance (in shares) at Dec. 31, 2020				33,039,146
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued in acquisitions (in shares)					6,636,470	530,502
Shares issued in acquisitions		$ 232,741	$ 31,977		$ 7			$ 232,734	$ 31,977
Fees incurred for registration filings	(186)						(186)
Stock-based compensation	13,956						13,956
Stock option exercises (in shares)				869,065
Stock option exercises	1,418			$ 1			1,417
Cashless exercises of warrants (in shares)				70,030
Cashless exercises of warrants	2,901						2,901
Stock issued – on vested RSAs (in shares)				672,290
Stock issued – on vested RSAs	1			$ 1
Foreign currency translation	(282)									(282)
Net loss	(8,908)										(8,908)
Preferred stock, ending balance (in shares) at Dec. 31, 2021													0
Ending balance at Dec. 31, 2021	478,047			$ 42			585,397			(282)	(107,110)		$ 0
Common Stock, ending balance (in shares) at Dec. 31, 2021				41,817,503
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issued as consideration for SciSafe earnout (in shares)				64,130
Stock issued as consideration for SciSafe earnout	817						817
Fees incurred for registration filings	(131)						(131)
Stock-based compensation	$ 25,334						25,334
Stock option exercises (in shares)	161,646
Stock option exercises	$ 323						323
Stock issued – on vested RSAs (in shares)				788,952
Stock issued – on vested RSAs	0			$ 1			(1)
Other comprehensive loss	(397)									(397)
Net loss	(139,805)										(139,805)
Preferred stock, ending balance (in shares) at Dec. 31, 2022												0	0
Ending balance at Dec. 31, 2022	$ 364,188			$ 43			611,739			(679)	(246,915)		$ 0
Common Stock, ending balance (in shares) at Dec. 31, 2022	42,832,231			42,832,231
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issued as consideration for SciSafe earnout (in shares)				116,973
Stock issued as consideration for SciSafe earnout	$ 2,263						2,263
Fees incurred for registration filings	(132)						(132)
Stock-based compensation	31,670						31,670
Stock option exercises (in shares)				239,043
Stock option exercises	507						507
Stock issued – on vested RSAs (in shares)				1,267,837
Stock issued – on vested RSAs	0			$ 1			(1)
Settlement of Global Cooling escrow (in shares)				(216,024)
Settlement of Global Cooling escrow	(5,115)						(5,115)
Common stock shares issued (in shares)				927,165
Common stock shares issued	10,375			$ 1			10,374
Other comprehensive loss	334									334
Net loss	(66,427)										(66,427)
Preferred stock, ending balance (in shares) at Dec. 31, 2023												0	0
Ending balance at Dec. 31, 2023	$ 337,663			$ 45			$ 651,305			$ (345)	$ (313,342)		$ 0
Common Stock, ending balance (in shares) at Dec. 31, 2023	45,167,225			45,167,225